Trades on 1 secondary market

Stylus Medicine

Stylus Medicine is a Cambridge, Massachusetts biotechnology company developing in vivo genetic medicines built on engineered recombinases. Its platform aims to generate precise, durable CAR-T cells directly inside the body using cell-targeted lipid nanoparticle delivery to immune cells, with therape

minimal 7.7 / 100 0 APIs View provider profile →

Company Biotechnology Genetic Medicine CAR-T Cell Therapy Oncology

Stylus Medicine is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.